NYSE - Nasdaq Real Time Price USD

Haleon plc (HLN)

10.44

-0.27

(-2.57%)

As of 12:18:35 PM EDT. Market Open.

Can Mixed Fundamentals Have A Negative Impact on Haleon plc (LON:HLN) Current Share Price Momentum?

Most readers would already be aware that Haleon's (LON:HLN) stock increased significantly by 13% over the past month...

Simply Wall St. 5 days ago

HLN
-2.57%

HLNCF
Brightseed and Haleon Announce Strategic Collaboration to Harness AI for Small Molecule Discovery and Human Health Innovation

LONDON & SAN FRANCISCO, May 01, 2025--Brightseed and Haleon and Announce Strategic Collaboration to Harness AI for Small Molecule Discovery and Human Health Innovation

Business Wire 12 days ago

HLN
-2.57%

HLNCF
Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca

Earnings preview of key companies reporting next week and what to look out for.

Yahoo Finance UK 18 days ago

VSCFF

GBPEUR=X

GBP=X
Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals

Pfizer sells 7.3% remaining stake in Haleon. FDA approves the expanded use of JNJ and NVS drugs.

Zacks last month

AZN

HLN
-2.57%

PFE
Sensodyne-maker axes diversity targets from bonuses

Haleon is to axe diversity targets from its executive bonus scheme in the latest sign that UK businesses are rowing back on DEI.

The Telegraph last month

HLN
-2.57%
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B

Pfizer divests its 7.3% remaining stake in Haleon to institutional investors and Haleon itself.

Zacks last month

PFE

HLN
-2.57%
Pfizer sells 7.3% stake in Haleon for $3.3bn

The disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.

Pharmaceutical Technology last month

PFE

HLN
-2.57%
Top Midday Stories: EC Notifies Alphabet of DMA Noncompliance, Adopts Requirements for Apple; Boeing Expects Less Q1 Cash Outflow

All three major US stock indexes were up in late-morning trading as investors await the Federal Rese

PREMIUM
MT Newswires last month

BA

HLN
-2.57%

PFE
Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant

Pfizer offloads its 7.3% Haleon stake, raising $3.24B as BlackRock emerges as the new top shareholder

GuruFocus.com last month

PFE

HLN
-2.57%

GSK
Pfizer offloads final shares in Sensodyne maker Haleon

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US rival Pfizer.

PA Media: Money last month

PFE

HLN
-2.57%
Pfizer sells entire Haleon stake for $3.24 billion

Under the deal, Sensodyne maker Haleon has agreed to buy back 44 million shares from Pfizer, currently its largest shareholder, with 618 million shares being sold to institutional investors. The total sale represents 7.3% of the issued share capital of Haleon, which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019.

Reuters last month

PFE

HLN
-2.57%
Teva Pharmaceutical Stock Scores RS Rating Upgrade

Teva Pharmaceutical ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investor's Business Daily last month

COLL

ANIP

HLN
-2.57%
Pfizer to sell entire Haleon stake

Pfizer will sell about 662 million ordinary shares, or 7.3%, of Haleon, created in a merger of GSK and Pfizer's consumer healthcare businesses in 2019, and spun off in 2022. Under the deal, the Sensodyne maker has agreed to buy back shares worth $220 million from Pfizer, currently its largest shareholder.

Reuters last month

PFE

HLN
-2.57%
As trade war intensifies, Reckitt may be more exposed than some rivals

Some investors fear Reckitt may be forced to raise its prices in the United States or face higher costs as its low manufacturing capacity there compared to some rivals leaves the company more exposed to new U.S. tariffs on imports from Mexico. Reckitt, which makes Lysol cleaning products and Durex condoms, has five factories in the United States. It told Reuters in early March that it manufactures about 57% of its U.S. sales volumes locally, with the other 43% coming from places including Mexico and Southeast Asia.

Reuters last month

RBGLY

HLN
-2.57%
Jim Cramer on Haleon plc (HLN): ‘Stock Has Been Up’

We recently published an article titled Jim Cramer Discusses These 11 Stocks & President Trump’s Tariffs. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other stocks Jim Cramer discussed. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented on President Trump’s latest […]

Insider Monkey last month

HLN
-2.57%
Why Haleon plc (HLN) Surged On Monday?

We recently published a list of 10 Stocks Lead Monday’s Charge Amid Market Bloodbath. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath. The stock market kicked off the trading week in a bloodbath, erasing last week’s gains, […]

Insider Monkey 2 months ago

HLN
-2.57%
Haleon PLC (HLN) (Q4 2024) Earnings Call Highlights: Strong Growth in Emerging Markets Amid ...

Haleon PLC (HLN) reports robust performance in India and China, while navigating FX headwinds and inventory management issues.

GuruFocus.com 2 months ago

HLN
-2.57%
Haleon Full Year 2024 Earnings: EPS Misses Expectations

Haleon ( LON:HLN ) Full Year 2024 Results Key Financial Results Revenue: UK£11.2b (flat on FY 2023). Net income...

Simply Wall St. 2 months ago

HLN
-2.57%

HLNCF
Is Haleon plc (HLN) the Best Low Price Pharma Stock to Invest In Right Now?

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma stocks. The Rising Demand for Weight-Loss Medications and GLP-1 Developments Healthcare, which includes numerous businesses that offer patient […]

Insider Monkey 2 months ago

HLN
-2.57%
Haleon beats Q4 organic growth estimates, but shares fall on 2025 guide

Investing.com -- HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year.

Investing.com 2 months ago

HLN
-2.57%

Performance Overview

Return	HLN	FTSE 100 (^FTSE)
YTD	+10.99%	+5.26%
1-Year	+28.76%	+2.23%
3-Year	+40.82%	+15.97%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Haleon plc (HLN)

Can Mixed Fundamentals Have A Negative Impact on Haleon plc (LON:HLN) Current Share Price Momentum?

Brightseed and Haleon Announce Strategic Collaboration to Harness AI for Small Molecule Discovery and Human Health Innovation

Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca

Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals

Sensodyne-maker axes diversity targets from bonuses

Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B

Pfizer sells 7.3% stake in Haleon for $3.3bn

Top Midday Stories: EC Notifies Alphabet of DMA Noncompliance, Adopts Requirements for Apple; Boeing Expects Less Q1 Cash Outflow

Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant

Pfizer offloads final shares in Sensodyne maker Haleon

Pfizer sells entire Haleon stake for $3.24 billion

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Pfizer to sell entire Haleon stake

As trade war intensifies, Reckitt may be more exposed than some rivals

Jim Cramer on Haleon plc (HLN): ‘Stock Has Been Up’

Why Haleon plc (HLN) Surged On Monday?

Haleon PLC (HLN) (Q4 2024) Earnings Call Highlights: Strong Growth in Emerging Markets Amid ...

Haleon Full Year 2024 Earnings: EPS Misses Expectations

Is Haleon plc (HLN) the Best Low Price Pharma Stock to Invest In Right Now?

Haleon beats Q4 organic growth estimates, but shares fall on 2025 guide

Performance Overview